Concepedia

Publication | Open Access

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial

DOIFull Paper Access

142

Citations

36

References

2017

Year

Howard E. Gendelman, Yuning Zhang, Pamela M. Santamaria, Katherine E. Olson, Charles R. Schutt, Danish Bhatti, Bhagya Laxmi Dyavar Shetty, Yaman Lu, Katherine A. Estes, David G. Standaert,
npj Parkinson s Disease

References

YearCitations

Page 1